Extended adjuvant treatment of patients with HER2+ early breast cancer with neratinib: a multi-centric, prospective, non-interventional study (NIS) in Germany and Austria (ELEANOR) by R. Bartsch, D. Lüftner, M. Balic, G. Rinnerthaler, C. Jackisch, V. Müller, M. Schmidt, N. Harbeck

Get full text

Neratinib as extended adjuvant therapy in patients with HER2-positive/HR-positive early breast cancer: German HTA-driven analyses from the ExteNET study by D. Lüftner, H. Tesch, M. Schmidt, A. Hartkopf, S. Streicher, A. Resch, L. Genovese, C. Rosé, R. Valenti, N. Harbeck

Get full text

Energy offsets within a molecular monolayer: the influence of the molecular environment by M Willenbockel, B Stadtmüller, K Schönauer, F C Bocquet, D Lüftner, E M Reinisch, T Ules, G Koller, C Kumpf, S Soubatch, P Puschnig, M G Ramsey, F S Tautz

Get full text

P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with e... by R. Bartsch, N. Harbeck, D. Wrobel, M. Zaiss, J. Terhaag, D. Guth, A. Distelrath, R. Wuerstlein, M.-O. Zahn, D. Lüftner, M. Schwitter, M. Balic, C. Jackisch, V. Müller, G. Rinnerthaler, M. Schmidt, K. Zaman, T. Schinköthe, M. Gorray, U. Breitenstein

Get full text